Concepedia

Jennie de Verdier

JD

3

Publications

147

Citations

3

H-Index

2007

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Jennie de Verdier is an author at AstraZeneca (Sweden) specializing in nanomedicine, chromatography, and chemical engineering.

Top concepts

Publications per year

2007–2007

3

Publications

3

Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy

Erik Lindström, Bengt von Mentzer, Ingrid Påhlman et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 70 citations

A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound

Kalle Sigfridsson, Sara Forssén, P. H. C. den Hollander et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2007 · 66 citations

, , +10

Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists

Monika Sundqvist, Elin Kristensson, Agnes Leffler et al. · European Journal of Pharmacology · 2007 · 11 citations

, , +6

Rows per page

1–3 of 3